dc.contributor.author |
Müller, Timo Dirk |
|
dc.date.accessioned |
2024-12-04T10:33:57Z |
|
dc.date.available |
2024-12-04T10:33:57Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
0012-1797 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/159305 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Alexandria, VA. : American Diabetes Association |
de_DE |
dc.relation.uri |
https://dx.doi.org/10.2337/dbi20-0025 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
A New FGF21 Analog for the Treatment of Fatty Liver Disease |
de_DE |
dc.type |
Article |
de_DE |
utue.publikation.seiten |
1605-1607 |
de_DE |
utue.personen.roh |
Kleinert, Maximilian |
|
utue.personen.roh |
Müller, Timo Dirk |
|
dcterms.isPartOf.ZSTitelID |
Diabetes |
de_DE |
dcterms.isPartOf.ZS-Issue |
8 |
de_DE |
dcterms.isPartOf.ZS-Volume |
69 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |